NCT04582110View on ClinicalTrials.gov

The Role of OCTA in Patients Affected by Beta Thalassemia

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

February 25, 2020

Study Completion Date

February 28, 2020

Conditions
Thalassemia
Interventions
DIAGNOSTIC_TEST

Optical coherence tomography angiography

Each subject underwent Optical coherence tomography angiography (a non-invasive, fast, diagnostic imaging technique)

Trial Locations (1)

80100

"University of Naples Federico II", Naples

All Listed Sponsors
lead

Federico II University

OTHER

NCT04582110 - The Role of OCTA in Patients Affected by Beta Thalassemia | Biotech Hunter | Biotech Hunter